Alogliptin and Pioglitazone

Padagis Israel Pharmaceuticals Ltd🇺🇸 United States

FDA Page

Effective Date: Sep 20, 2022
Approval ID: 642b1e90-701e-42f2-bac6-a4918738e2c9
Products: 6 registered
Version: 9

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use ALOGLIPTIN AND PIOGLITAZONE TABLETS safely and effectively. See full prescribing information for ALOGLIPTIN AND PIOGLITAZONE TABLETS. Alogliptin and Pioglitazone Tablets, for oral use Initial U.S. Approval: 2013

Quick Stats

Total Products6

Labelers2

Label Sections42

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.